Polycyclic aromatic hydrocarbon exposures of children in low-income families

J C Chuang1, P J Callahan, C W Lyu

  • 1National Exposure Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA. chuangj@battelle.org

Insights

Children in low-income families face high polycyclic aromatic hydrocarbon (PAH) exposures, particularly from indoor sources like environmental tobacco smoke. Inhalation is a key exposure route for children, while dietary intake is significant for specific carcinogens.

Area of Science:

  • Environmental Health
  • Toxicology
  • Public Health

Background:

  • Children in low-income households often experience elevated exposure to environmental pollutants like polycyclic aromatic hydrocarbons (PAH).
  • Sources of PAH exposure include proximity to traffic, industrial emissions, environmental tobacco smoke, and contaminated indoor dust or soil.
  • Understanding these exposures is critical for developing targeted public health interventions.

Purpose of the Study:

  • To develop and validate methods for measuring total PAH exposure in children from low-income families.
  • To estimate the levels of PAH exposure experienced by these children.
  • To identify and quantify the relative importance of different environmental pathways contributing to children's PAH exposure.

Main Methods:

  • Evaluated and validated analytical techniques for PAH in environmental media (air, dust, soil, food) and hydroxy-PAH in urine.
  • Conducted pilot and field studies in Durham, NC, and the NC Piedmont area, including winter and summer sampling in smoker and nonsmoker households.
  • Collected multimedia samples and analyzed for PAH and hydroxy-PAH, utilizing statistical analyses including summary statistics, Pearson correlations, and ANOVA.

Main Results:

  • Established an effective screening method for recruiting low-income families and a suitable field protocol for large-scale studies.
  • Indoor PAH levels were generally higher than outdoor levels, with significantly higher levels in smokers' homes.
  • Children exhibited higher potential daily PAH doses than adults (normalized to body weight), with inhalation being a major pathway for total PAH exposure due to naphthalene, and ingestion pathways significant for low-volatility B2 PAH.

Conclusions:

  • Indoor environments, particularly those with environmental tobacco smoke, are significant sources of PAH exposure for children in low-income families.
  • Inhalation of volatile PAHs like naphthalene and ingestion of less volatile PAHs contribute substantially to children's overall PAH burden.
  • Inner-city residents experienced higher total exposure to B2 PAH compared to rural residents, highlighting the impact of urban environmental factors.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...